SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Colleen K. Correll, Bryce A. Binstadt, Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis, Pediatric Research, 2014, 75, 1-2, 176

    CrossRef

  2. 2
    Isabelle Koné-Paut, Caroline Galeotti, Anakinra for cryopyrin-associated periodic syndrome, Expert Review of Clinical Immunology, 2014, 10, 1, 7

    CrossRef

  3. 3
    Jasmin B. Kuemmerle-Deschner, Samuel Dembi Samba, Pascal N. Tyrrell, Isabelle Koné-Paut, Isabelle Marie, Norbert Deschner, Susanne M. Benseler, Challenges in Diagnosing Muckle-Wells Syndrome: Identifying Two Distinct Phenotypes, Arthritis Care & Research, 2014, 66, 5
  4. 4
    N. Alejandre, A. Ruiz-Palacios, A. M. Garcia-Aparicio, F. Blanco-Kelly, S. Bermudez, G. Fernandez-Sanz, F. I. Romero, J. I. Arostegui, C. Ayuso, I. Jimenez-Alfaro, G. Herrero-Beaumont, O. Sanchez-Pernaute, Description of a new family with cryopyrin-associated periodic syndrome: risk of visual loss in patients bearing the R260W mutation, Rheumatology, 2014, 53, 6, 1095

    CrossRef

  5. 5
    R. A. G. Russo, S. Melo-Gomes, H. J. Lachmann, K. Wynne, K. Rajput, D. Eleftheriou, C. Edelsten, P. N. Hawkins, P. A. Brogan, Efficacy and safety of canakinumab therapy in paediatric patients with cryopyrin-associated periodic syndrome: a single-centre, real-world experience, Rheumatology, 2014, 53, 4, 665

    CrossRef

  6. 6
    R. A. G. Russo, P. A. Brogan, Monogenic autoinflammatory diseases, Rheumatology, 2014,

    CrossRef

  7. 7
    Joe Thomas, Boby V. Maramattom, Muckle wells syndrome associated with multifocal clinically isolated syndrome, International Journal of Rheumatic Diseases, 2014, 17, 3
  8. 8
    Alexander P. Headley, Frank Cordingley, Phillip N. Hawkins, D. Sean Riminton, Muckle–Wells Cryopyrinopathy: Complex Phenotyping and Response to Therapy in a New Multiplex Kindred, Inflammation, 2014, 37, 2, 396

    CrossRef

  9. 9
    S. Yuksel, E. Eren, G. Hatemi, A. C. Sahillio lu, Y. Gultekin, D. Demiroz, C. Akdis, I. Fresko, N. Ozoren, Novel NLRP3/cryopyrin mutations and pro-inflammatory cytokine profiles in Behcet's syndrome patients, International Immunology, 2014, 26, 2, 71

    CrossRef

  10. 10
    Nisha Mehta, Maninder Kaur, Manjinder Singh, Sukhvir Chand, Bhawna Vyas, Pragati Silakari, Malkeet Singh Bahia, Om Silakari, Purinergic receptor P2X7: A novel target for anti-inflammatory therapy, Bioorganic & Medicinal Chemistry, 2014, 22, 1, 54

    CrossRef

  11. 11
    Francesco Caso, Luca Cantarini, Orso Maria Lucherini, Paolo Sfriso, Maria Fioretti, Luisa Costa, Antonio Vitale, Mariangela Atteno, Mauro Galeazzi, Isabella Muscari, Flora Magnotti, Bruno Frediani, Leonardo Punzi, Donato Rigante, Working the endless puzzle of hereditary autoinflammatory disorders, Modern Rheumatology, 2014, 24, 3, 381

    CrossRef

  12. 12
    Adriana A. de Jesus, Polly J. Ferguson, Raphaela Goldbach-Mansky, Stiehm's Immune Deficiencies, 2014,

    CrossRef

  13. 13
    Tien V. Nguyen, Edward W. Cowen, Kieron S. Leslie, Autoinflammation: From monogenic syndromes to common skin diseases, Journal of the American Academy of Dermatology, 2013, 68, 5, 834

    CrossRef

  14. 14
    Jonathan S. Hausmann, Fatma Dedeoglu, Autoinflammatory Diseases in Pediatrics, Dermatologic Clinics, 2013, 31, 3, 481

    CrossRef

  15. 15
    Nico M Wulffraat, Patricia Woo, Canakinumab in pediatric rheumatic diseases, Expert Opinion on Biological Therapy, 2013, 13, 4, 615

    CrossRef

  16. 16
    Dorota M Rowczenio, Hadija Trojer, Tonia Russell, Anna Baginska, Thirusha Lane, Nicola M Stewart, Julian D Gillmore, Philip N Hawkins, Patricia Woo, Bozena Mikoluc, Helen J Lachmann, Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature, Arthritis Research & Therapy, 2013, 15, 1, R30

    CrossRef

  17. 17
    Thomas J. Oberg, Albert T. Vitale, Robert O. Hoffman, John F. Bohnsack, Judith E. Warner, Cryopyrin-associated Periodic Syndromes and the Eye, Ocular Immunology and Inflammation, 2013, 21, 4, 306

    CrossRef

  18. 18
    Jasmin B. Kuemmerle-Deschner, Assen Koitschev, Katharina Ummenhofer, Sandra Hansmann, Stefan K. Plontke, Christiane Koitschev, Ina Koetter, Eva Angermair, Susanne M. Benseler, Hearing loss in Muckle-Wells syndrome, Arthritis & Rheumatism, 2013, 65, 3
  19. 19
    James T. Rosenbaum, Hyun Woong Kim, Innate Immune Signals in Autoimmune and Autoinflammatory Uveitis, International Reviews of Immunology, 2013, 32, 1, 68

    CrossRef

  20. 20
    Hugh Tilson, Paola Primatesta, Dennis Kim, Barbara Rauer, Philip N Hawkins, Hal M Hoffman, Jasmin Kuemmerle-Deschner, Tom van der Poll, Ulrich A Walker, Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry, Orphanet Journal of Rare Diseases, 2013, 8, 1, 139

    CrossRef

  21. 21
    Gina A. Montealegre Sanchez, Adriana Almeida de Jesus, Raphaela Goldbach-Mansky, Monogenic Autoinflammatory Diseases, Rheumatic Disease Clinics of North America, 2013, 39, 4, 701

    CrossRef

  22. 22
    Adriana Almeida de Jesus, Raphaela Goldbach-Mansky, Monogenic autoinflammatory diseases: Concept and clinical manifestations, Clinical Immunology, 2013, 147, 3, 155

    CrossRef

  23. 23
    Christoph Kessel, Dirk Holzinger, Dirk Foell, Phagocyte-derived S100 proteins in autoinflammation: Putative role in pathogenesis and usefulness as biomarkers, Clinical Immunology, 2013, 147, 3, 229

    CrossRef

  24. 24
    David Lobo, José R. García-Berrocal, Almudena Trinidad, José M. Verdaguer, Rafael Ramírez-Camacho, Review of the Biological Agents Used for Immune-Mediated Inner Ear Disease, Acta Otorrinolaringologica (English Edition), 2013, 64, 3, 223

    CrossRef

  25. 25
    David Lobo, José R. García-Berrocal, Almudena Trinidad, José M. Verdaguer, Rafael Ramírez-Camacho, Revisión de las terapias biológicas en la enfermedad inmunomediada del oído interno, Acta Otorrinolaringológica Española, 2013, 64, 3, 223

    CrossRef

  26. 26
    A C Hall, A C Leong, D Jiang, A Fitzgerald-O'Connor, Sudden bilateral sensorineural hearing loss associated with urticarial vasculitis, The Journal of Laryngology & Otology, 2013, 127, 07, 708

    CrossRef

  27. 27
    Alexander So, Annette Ives, Leo A. B. Joosten, Nathalie Busso, Targeting inflammasomes in rheumatic diseases, Nature Reviews Rheumatology, 2013, 9, 7, 391

    CrossRef

  28. 28
    Christopher Chang, The pathogenesis of neonatal autoimmune and autoinflammatory diseases: A comprehensive review, Journal of Autoimmunity, 2013, 41, 100

    CrossRef

  29. 29
    Charles A. Dinarello, Jos W.M. van der Meer, Treating inflammation by blocking interleukin-1 in humans, Seminars in Immunology, 2013, 25, 6, 469

    CrossRef

  30. 30
    Jasmin B Kuemmerle-Deschner, Helmut Wittkowski, Pascal N Tyrrell, Ina Koetter, Peter Lohse, Katharina Ummenhofer, Fabian Reess, Sandra Hansmann, Assen Koitschev, Christoph Deuter, Anja Bialkowski, Dirk Foell, Susanne M Benseler, Treatment of Muckle-Wells syndrome: analysis of two IL-1-blocking regimens, Arthritis Research & Therapy, 2013, 15, 3, R64

    CrossRef

  31. 31
    Zuhre Tutuncu, Arthur Kavanaugh, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  32. 32
    C. M. Hedrich, N. Bruck, D. Paul, G. Hahn, M. Gahr, A. Rösen-Wolff, “Mutation negative” familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies, Rheumatology International, 2012, 32, 9, 2629

    CrossRef

  33. 33
    C. A. Beamer, B. P. Seaver, D. M. Shepherd, Aryl Hydrocarbon Receptor (AhR) Regulates Silica-Induced Inflammation But Not Fibrosis, Toxicological Sciences, 2012, 126, 2, 554

    CrossRef

  34. 34
    Roberta Caorsi, Silvia Federici, Marco Gattorno, Biologic drugs in autoinflammatory syndromes, Autoimmunity Reviews, 2012, 12, 1, 81

    CrossRef

  35. 35
    Joe C Furr, Mukta Panda, Cold-induced urticaria with a familial transmission: a case report and review of the literature, Journal of Medical Case Reports, 2012, 6, 1, 70

    CrossRef

  36. 36
    David Ellinghaus, Eva Ellinghaus, Rajan P. Nair, Philip E. Stuart, Tõnu Esko, Andres Metspalu, Sophie Debrus, John V. Raelson, Trilokraj Tejasvi, Majid Belouchi, Sarah L. West, Jonathan N. Barker, Sulev Kõks, Külli Kingo, Tobias Balschun, Orazio Palmieri, Vito Annese, Christian Gieger, H. Erich Wichmann, Michael Kabesch, Richard C. Trembath, Christopher G. Mathew, Gonçalo R. Abecasis, Stephan Weidinger, Susanna Nikolaus, Stefan Schreiber, James T. Elder, Michael Weichenthal, Michael Nothnagel, Andre Franke, Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci, The American Journal of Human Genetics, 2012, 90, 4, 636

    CrossRef

  37. 37
    Hal M. Hoffman, Martin L. Throne, Niran J. Amar, Robert C. Cartwright, Alan J. Kivitz, Yuhwen Soo, Steven P. Weinstein, Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study, Clinical Therapeutics, 2012, 34, 10, 2091

    CrossRef

  38. 38
    James W. Verbsky, Monogenic causes of inflammatory disease in rheumatology, Current Opinion in Rheumatology, 2012, 24, 5, 506

    CrossRef

  39. 39
    Christopher Chang, Neonatal autoimmune diseases: A critical review, Journal of Autoimmunity, 2012, 38, 2-3, J223

    CrossRef

  40. 40
    Ahmad Bakir Tarabishy, Amy G. Hise, Elias I. Traboulsi, Ocular manifestations of the autoinflammatory syndromes, Ophthalmic Genetics, 2012, 33, 4, 179

    CrossRef

  41. 41
    Assen Koitschev, Katharina Gramlich, Sandra Hansmann, Susanne Benseler, Stefan K. Plontke, Christiane Koitschev, Ina Koetter, Jasmin B. Kuemmerle-Deschner, Progressive familial hearing loss in Muckle-Wells syndrome, Acta Oto-laryngologica, 2012, 132, 7, 756

    CrossRef

  42. 42
    Jangwon Heo, Yasir J Sepah, Jithin Yohannan, Morgan Renner, Abeer Akhtar, Anthony Gregory, Mathew Shulman, Diana V Do, Quan Dong Nguyen, The role of biologic agents in the management of non-infectious uveitis, Expert Opinion on Biological Therapy, 2012, 12, 8, 995

    CrossRef

  43. 43
    Kristina Ludigs, Valeriy Parfenov, Renaud A. Du Pasquier, Greta Guarda, Type I IFN-mediated regulation of IL-1 production in inflammatory disorders, Cellular and Molecular Life Sciences, 2012, 69, 20, 3395

    CrossRef

  44. 44
    N.J.D. Weegerink, M. Schraders, J. Leijendeckers, K. Slieker, P.L.M. Huygen, L. Hoefsloot, J. Oostrik, R.J.E. Pennings, A. Simon, A. Snik, H. Kremer, H.P.M. Kunst, Audiometric characteristics of a Dutch family with Muckle-Wells syndrome, Hearing Research, 2011, 282, 1-2, 243

    CrossRef

  45. 45
    J. Schedel, B. Bach, J.B. Kümmerle-Deschner, I. Kötter, Autoinflammatorische Syndrome/Fiebersyndrome, Der Hautarzt, 2011, 62, 5, 389

    CrossRef

  46. 46
    Toshio Heike, Megumu K Saito, Ryuta Nishikomori, Takahiro Yasumi, Tatsutoshi Nakahata, Autoinflammatory diseases - a new entity of inflammation, Inflammation and Regeneration, 2011, 31, 2, 125

    CrossRef

  47. You have free access to this content47
    C. A. Dinarello, Blocking interleukin-1β in acute and chronic autoinflammatory diseases, Journal of Internal Medicine, 2011, 269, 1
  48. 48
    Aarat M. Patel, Kathryn S. Torok, Canakinumab for the treatment of adult and pediatric cryopyrin-associated periodic syndromes (CAPS), Drug Development Research, 2011, 72, 7
  49. 49
    Justin R. Yu, Kieron S. Leslie, Cryopyrin-Associated Periodic Syndrome: An Update on Diagnosis and Treatment Response, Current Allergy and Asthma Reports, 2011, 11, 1, 12

    CrossRef

  50. 50
    Annalisa Marcuzzi, Elisa Piscianz, Martina Girardelli, Sergio Crovella, Alessandra Pontillo, Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes, Apoptosis, 2011, 16, 9, 882

    CrossRef

  51. 51
    Jasmin B. Kuemmerle-Deschner, Pascal N. Tyrrell, Ina Koetter, Helmut Wittkowski, Anja Bialkowski, Nicolai Tzaribachev, Peter Lohse, Assen Koitchev, Christoph Deuter, Dirk Foell, Susanne M. Benseler, Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome, Arthritis & Rheumatism, 2011, 63, 3
  52. 52
    Ivona Aksentijevich, Daniel L. Kastner, Genetics of monogenic autoinflammatory diseases: past successes, future challenges, Nature Reviews Rheumatology, 2011, 7, 8, 469

    CrossRef

  53. 53
    C. A. Dinarello, Interleukin-1 in the pathogenesis and treatment of inflammatory diseases, Blood, 2011, 117, 14, 3720

    CrossRef

  54. 54
    James Galea, Kayode Ogungbenro, Sharon Hulme, Andrew Greenhalgh, Leon Aarons, Sylvia Scarth, Peter Hutchinson, Samantha Grainger, Andrew King, Stephen J Hopkins, Nancy Rothwell, Pippa Tyrrell, Intravenous anakinra can achieve experimentally effective concentrations in the central nervous system within a therapeutic time window: results of a dose-ranging study, Journal of Cerebral Blood Flow & Metabolism, 2011, 31, 2, 439

    CrossRef

  55. 55
    L. Newell, S. August, V. Foria, K. Godfrey, Lifelong urticaria and multiple unexplained systemic symptoms, Clinical and Experimental Dermatology, 2011, 36, 4
  56. 56
    P. Woo, R. E. Petty, Looking at paediatric rheumatology over the past 50 years, Rheumatology, 2011, 50, 9, 1533

    CrossRef

  57. 57
    Simon M. Mueller, Peter Itin, Peter Haeusermann, Muckle-Wells Syndrome Effectively Treated with Canakinumab: Is the Recommended Dosing Schedule Mandatory?, Dermatology, 2011, 223, 2, 113

    CrossRef

  58. 58
    Jasmin B Kuemmerle-Deschner, Peter Lohse, Ina Koetter, Guenther E Dannecker, Fabian Reess, Katharina Ummenhofer, Silvia Koch, Nikolay Tzaribachev, Anja Bialkowski, Susanne M Benseler, NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment, Arthritis Research & Therapy, 2011, 13, 6, R196

    CrossRef

  59. 59
    Victoria M. Wurster, James G. Carlucci, Kathryn M. Edwards, Periodic Fever Syndromes, Pediatric Annals, 2011, 40, 1, 48

    CrossRef

  60. 60
    Raquel Cuchacovich, Ignacio Garcia-Valladares, Luis R Espinoza, Pleiotropic effects of inflammasome modulation in chronic gout and associated comorbidities: potential therapeutic implications, International Journal of Clinical Rheumatology, 2011, 6, 6, 669

    CrossRef

  61. 61
    Yelda Bilginer, Tekin Akpolat, Seza Ozen, Renal amyloidosis in children, Pediatric Nephrology, 2011, 26, 8, 1215

    CrossRef

  62. 62
    Inmaculada Calvo Penadés, Berta López Montesinos, Ana Marco Puche, Síndrome de Muckle-Wells y síndrome autoinflamatorio familiar inducido por frío, Medicina Clínica, 2011, 136, 16

    CrossRef

  63. You have free access to this content63
    P. Menu, J. E. Vince, The NLRP3 inflammasome in health and disease: the good, the bad and the ugly, Clinical & Experimental Immunology, 2011, 166, 1
  64. 64
    Santiago Jiménez Treviño, Eduardo Ramos Polo, Tratamiento de los síndromes periódicos asociados a la criopirina (CAPS), Medicina Clínica, 2011, 136, 29

    CrossRef

  65. 65
    Paul F Hwang, Nancy Porterfield, Dylan Pannell, Thomas A Davis, Eric A Elster, Trauma is danger, Journal of Translational Medicine, 2011, 9, 1, 92

    CrossRef

  66. 66
    Sara Axelrod, Mark Davis-Lorton, Urticaria and Angioedema, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2011, 78, 5
  67. 67
    Karyl Barron, Balu Athreya, Daniel Kastner, Textbook of Pediatric Rheumatology, 2011,

    CrossRef

  68. 68
    Ellen M. Gravallese, Paul A. Monach, Rheumatology, 2011,

    CrossRef

  69. 69
    Josephine L. Reece, Jeffrey D. Lancaster, Linda S. Nield, A 16-Year-Old Male with Recurrent Inflammation and Hearing Loss, Pediatric Annals, 2010, 39, 12, 753

    CrossRef

  70. 70
    Juan I. Aróstegui, Ma Dolores Lopez Saldaña, Mariona Pascal, Daniel Clemente, Marta Aymerich, Francesc Balaguer, Ajay Goel, Concepción Fournier del Castillo, Josefa Rius, Susana Plaza, Juan Carlos López Robledillo, Manel Juan, Mercedes Ibañez, Jordi Yagüe, A somatic NLRP3 mutation as a cause of a sporadic case of chronic infantile neurologic, cutaneous, articular syndrome/neonatal-onset multisystem inflammatory disease: Novel evidence of the role of low-level mosaicism as the pathophysiologic mechanism underlying mendelian inherited diseases, Arthritis & Rheumatism, 2010, 62, 4
  71. 71
    Tom Pettersson, Yrjö T. Konttinen, Amyloidosis—Recent Developments, Seminars in Arthritis and Rheumatism, 2010, 39, 5, 356

    CrossRef

  72. 72
    Tassadit Aït-Abdesselam, Thierry Lequerré, Bruno Legallicier, Arnaud François, Xavier Le Loët, Olivier Vittecoq, Anakinra efficacy in a Caucasian patient with renal AA amyloidosis secondary to cryopyrin-associated periodic syndrome, Joint Bone Spine, 2010, 77, 6, 616

    CrossRef

  73. 73
    G. Lionetti, S. Lapidus, R. Goldbach-Mansky, J. Frankovich, Autoinflammatory Diseases in the Neonate: Mimickers of Neonatal Infections, NeoReviews, 2010, 11, 10, e566

    CrossRef

  74. 74
    Manfred Kopf, Martin F. Bachmann, Benjamin J. Marsland, Averting inflammation by targeting the cytokine environment, Nature Reviews Drug Discovery, 2010, 9, 9, 703

    CrossRef

  75. 75
    Thomas Mandrup-Poulsen, Linda Pickersgill, Marc Yves Donath, Blockade of interleukin 1 in type 1 diabetes mellitus, Nature Reviews Endocrinology, 2010, 6, 3, 158

    CrossRef

  76. 76
    Antonio Torrelo, Sapna Patel, Isabel Colmenero, Dolores Gurbindo, Francisco Lendínez, Angela Hernández, Juan Carlos López-Robledillo, Ali Dadban, Luis Requena, Amy S. Paller, Chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature (CANDLE) syndrome, Journal of the American Academy of Dermatology, 2010, 62, 3, 489

    CrossRef

  77. 77
    Gayane Manukyan, Karine Ghazaryan, Zhanna Ktsoyan, Zaruhi Khachatryan, Denise Kelly, Marieta Tatyan, Marina Agababova, Rustam Aminov, Comparative analysis of cytokine profiles in autoinflammatory and autoimmune conditions, Cytokine, 2010, 50, 2, 146

    CrossRef

  78. 78
    Tassadit Aït-Abdesselam, Thierry Lequerré, Bruno Legallicier, Arnaud François, Xavier Le Loët, Olivier Vittecoq, Efficacité de l’Anakinra chez un patient caucasien présentant une amylose rénale AA secondaire à un syndrome périodique associé à la cryopyrine, Revue du Rhumatisme, 2010, 77, 5, 530

    CrossRef

  79. 79
    Laeticia Kolly, Nathalie Busso, Gaby Palmer, Dominique Talabot-Ayer, Véronique Chobaz, Alexander So, Expression and function of the NALP3 inflammasome in rheumatoid synovium, Immunology, 2010, 129, 2
  80. 80
    Prudence Joan Manners, Robin Guttinger, Fevers and the Rheumatologist, The Indian Journal of Pediatrics, 2010, 77, 10, 1173

    CrossRef

  81. 81
    James T Rosenbaum, Future for biological therapy for uveitis, Current Opinion in Ophthalmology, 2010, 21, 6, 473

    CrossRef

  82. 82
    Terri M. Laufer, Inflammatory arthritis - an exciting confluence of human and animal research, Immunological Reviews, 2010, 233, 1
  83. 83
    Bastian Opitz, Vincent van Laak, Julia Eitel, Norbert Suttorp, Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung, American Journal of Respiratory and Critical Care Medicine, 2010, 181, 12, 1294

    CrossRef

  84. 84
    Isabelle Touitou, Sylvie Grandemange, Les avancées génétiques dans les maladies auto-inflammatoires, Revue du Rhumatisme Monographies, 2010, 77, 4, 300

    CrossRef

  85. 85
    E. Hachulla, Les biothérapies hors AMM dans les maladies systémiques, La Revue de Médecine Interne, 2010, 31, S307

    CrossRef

  86. 86
    Bénédicte Neven, Isabelle Marvillet, Celine Terrada, Alice Ferster, Nathalie Boddaert, Vincent Couloignier, Graziella Pinto, Anne Pagnier, Christine Bodemer, Bahram Bodaghi, Marc Tardieu, Anne Marie Prieur, Pierre Quartier, Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome, Arthritis & Rheumatism, 2010, 62, 1
  87. 87
    Fabio Martinon, Mechanisms of uric acid crystal-mediated autoinflammation, Immunological Reviews, 2010, 233, 1
  88. 88
    Andrea A. Itano, Martin J. Sims, Gerald Siu, Mechanistic medicine: Novel strategies for clinical trials, Autoimmunity, 2010, 43, 7, 560

    CrossRef

  89. 89
    Cailin Henderson, Raphaela Goldbach-Mansky, Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: Finding the right balance in response to danger signals, Clinical Immunology, 2010, 135, 2, 210

    CrossRef

  90. 90
    Deb Biswas, Nick Stafford, Otolaryngological manifestations of ‘Muckle–Wells syndrome’, International Journal of Pediatric Otorhinolaryngology, 2010, 74, 5, 553

    CrossRef

  91. 91
    Zachary Jacobs, Christina E. Ciaccio, Periodic Fever Syndromes, Current Allergy and Asthma Reports, 2010, 10, 6, 398

    CrossRef

  92. 92
    Greta Guarda, Alexander So, Regulation of inflammasome activity, Immunology, 2010, 130, 3
  93. 93
    Jasmin B. Kümmerle-Deschner, Pascal N. Tyrrell, Fabian Reess, Ina Kötter, Peter Lohse, Hermann Girschick, Christian Huemer, Gerd Horneff, Johannes-Peter Haas, Assen Koitschev, Christoph Deuter, Susanne M. Benseler, Risk factors for severe Muckle-Wells syndrome, Arthritis & Rheumatism, 2010, 62, 12
  94. 94
    Seza Ozen, The “other” vasculitis syndromes and kidney involvement, Pediatric Nephrology, 2010, 25, 9, 1633

    CrossRef

  95. 95
    Kate Schroder, Jurg Tschopp, The Inflammasomes, Cell, 2010, 140, 6, 821

    CrossRef

  96. 96
    Andrew C. Chan, Paul J. Carter, Therapeutic antibodies for autoimmunity and inflammation, Nature Reviews Immunology, 2010, 10, 5, 301

    CrossRef

  97. 97
    Sreelatha Reddy, Shuang Jia, Rhonda Geoffrey, Rachel Lorier, Mariko Suchi, Ulrich Broeckel, Martin J. Hessner, James Verbsky, An Autoinflammatory Disease Due to Homozygous Deletion of theIL1RNLocus, New England Journal of Medicine, 2009, 360, 23, 2438

    CrossRef

  98. 98
    Dennis McGonagle, Azad Aziz, Laura J Dickie, Michael F McDermott, An Integrated Classification of Pediatric Inflammatory Diseases, Based on the Concepts of Autoinflammation and the Immunological Disease Continuum, Pediatric Research, 2009, 65, 5 Part 2, 38R

    CrossRef

  99. 99
    M. G. Netea, C. A. Nold-Petry, M. F. Nold, L. A. B. Joosten, B. Opitz, J. H. M. van der Meer, F. L. van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, C. J. Funk, R. J. Mason, B. J. Kullberg, A. Rubartelli, J. W. M. van der Meer, C. A. Dinarello, Differential requirement for the activation of the inflammasome for processing and release of IL-1  in monocytes and macrophages, Blood, 2009, 113, 10, 2324

    CrossRef

  100. 100
    Evelien J. Bodar, Joost P. H. Drenth, Jos W. M. Van Der Meer, Anna Simon, Dysregulation of innate immunity: hereditary periodic fever syndromes, British Journal of Haematology, 2009, 144, 3
  101. 101
    Andreas Kerstan, Martin Leverkus, Axel Trautmann, Effector pathways during eczematous dermatitis: where inflammation meets cell death, Experimental Dermatology, 2009, 18, 10
  102. 102
    B. Manger, M. Gaubitz, H. Michels, Empfehlungen zur Therapie mit Interleukin-1β-blockierenden Wirkstoffen, Zeitschrift für Rheumatologie, 2009, 68, 9, 766

    CrossRef

  103. 103
    Luigi Franchi, Neil Warner, Kyle Viani, Gabriel Nuñez, Function of Nod-like receptors in microbial recognition and host defense, Immunological Reviews, 2009, 227, 1
  104. 104
    Juan I. Aróstegui, Manifestaciones cutáneas en las enfermedades autoinflamatorias sistémicas, Piel, 2009, 24, 3, 139

    CrossRef

  105. 105
    GINA A MONTEALEGRE SANCHEZ, PHILIP J HASHKES, Neurological manifestations of the Mendelian-inherited autoinflammatory syndromes, Developmental Medicine & Child Neurology, 2009, 51, 6
  106. 106
    Srilakshmi M. Sharma, Andrew D. Dick, Athimalaipet V. Ramanan, Non-Infectious Pediatric Uveitis, Pediatric Drugs, 2009, 11, 4, 229

    CrossRef

  107. 107
    Ingrid I van Gameren, Edo Vellenga, Bouke PC Hazenberg, Novel treatments for systemic amyloidosis, International Journal of Clinical Rheumatology, 2009, 4, 2, 171

    CrossRef

  108. 108
    I. Kötter, J. Schedel, J.B. Kümmerle-Deschner, Periodische Fiebersyndrome/autoinflammatorische Syndrome, Zeitschrift für Rheumatologie, 2009, 68, 2, 137

    CrossRef

  109. 109
    O. Blétry, T. Sene, J.-E. Kahn, F. Ackermann, P. Charles, J. Leport, A.-M. Piette, Quoi de neuf en médecine interne ?, Annales de Dermatologie et de Vénéréologie, 2009, 136, S417

    CrossRef

  110. 110
    Hal M. Hoffman, Anna Simon, Recurrent febrile syndromes—what a rheumatologist needs to know, Nature Reviews Rheumatology, 2009, 5, 5, 249

    CrossRef

  111. 111
    Ke Ren, Richard Torres, Role of interleukin-1β during pain and inflammation, Brain Research Reviews, 2009, 60, 1, 57

    CrossRef

  112. 112
    M. Brenner, T. Ruzicka, G. Plewig, P. Thomas, P. Herzer, Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra, British Journal of Dermatology, 2009, 161, 5
  113. 113
    Linda M.S. Pickersgill, Thomas R. Mandrup-Poulsen, The anti-interleukin-1 in type 1 diabetes action trial—background and rationale, Diabetes/Metabolism Research and Reviews, 2009, 25, 4
  114. 114
    Sara Saperstein, Heidie Huyck, Elizabeth Kimball, Carl Johnston, Jacob Finkelstein, Gloria Pryhuber, The Effects of Interleukin-1βin Tumor Necrosis Factor-α-Induced Acute Pulmonary Inflammation in Mice, Mediators of Inflammation, 2009, 2009, 1

    CrossRef

  115. 115
    Luigi Franchi, Tatjana Eigenbrod, Raúl Muñoz-Planillo, Gabriel Nuñez, The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis, Nature Immunology, 2009, 10, 3, 241

    CrossRef

  116. 116
    Fabio Martinon, Annick Mayor, Jürg Tschopp, The Inflammasomes: Guardians of the Body, Annual Review of Immunology, 2009, 27, 1, 229

    CrossRef

  117. 117
    Tammy M. Martin, Zili Zhang, Paul Kurz, Carlos D. Rosé, Hong Chen, Huiying Lu, Stephen R. Planck, Michael P. Davey, James T. Rosenbaum, The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity, Arthritis & Rheumatism, 2009, 60, 2
  118. 118
    Hal M. Hoffman, Therapy of autoinflammatory syndromes, Journal of Allergy and Clinical Immunology, 2009, 124, 6, 1129

    CrossRef

  119. 119
    Ronald F. van Vollenhoven, Treatment of rheumatoid arthritis: state of the art 2009, Nature Reviews Rheumatology, 2009, 5, 10, 531

    CrossRef

  120. 120
    Helen J. Lachmann, Isabelle Kone-Paut, Jasmin B. Kuemmerle-Deschner, Kieron S. Leslie, Eric Hachulla, Pierre Quartier, Xavier Gitton, Albert Widmer, Neha Patel, Philip N. Hawkins, Use of Canakinumab in the Cryopyrin-Associated Periodic Syndrome, New England Journal of Medicine, 2009, 360, 23, 2416

    CrossRef

  121. 121
    Hal Hoffman, Alan Wanderer, Urticaria and Angioedema, Second Edition, 2009,

    CrossRef

  122. 122
    M Greaves, A Kaplan, C Grattan, Urticaria and Angioedema, Second Edition, 2009,

    CrossRef

  123. 123
    Peter C. Taylor, Rheumatoid Arthritis, 2009,

    CrossRef

  124. 124
    George Trendelenburg, Acute neurodegeneration and the inflammasome: central processor for danger signals and the inflammatory response?, Journal of Cerebral Blood Flow & Metabolism, 2008, 28, 5, 867

    CrossRef

  125. 125
    Takashi Yamazaki, Junya Masumoto, Kazunaga Agematsu, Nobukuni Sawai, Shinji Kobayashi, Tomonari Shigemura, Kozo Yasui, Kenichi Koike, Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome, Arthritis & Rheumatism, 2008, 58, 3
  126. 126
    Isabelle Touitou, Isabelle Koné-Paut, Autoinflammatory diseases, Best Practice & Research Clinical Rheumatology, 2008, 22, 5, 811

    CrossRef

  127. 127
    Maria Helena B. Kiss, Claudia Saad Magalhães, Autoinflammatory Diseases: Mimics of Autoimmunity or Part of its Spectrum? Case Presentation, Journal of Clinical Immunology, 2008, 28, S1, 84

    CrossRef

  128. 128
    Hal M. Hoffman, Frederick Wolfe, Pavel Belomestnov, Scott J. Mellis, Cryopyrin-associated periodic syndromes: development of a patient-reported outcomes instrument to assess the pattern and severity of clinical disease activity*, Current Medical Research and Opinion, 2008, 24, 9, 2531

    CrossRef

  129. 129
    K. Shinkai, T. H. McCalmont, K. S. Leslie, Cryopyrin-associated periodic syndromes and autoinflammation, Clinical and Experimental Dermatology, 2008, 33, 1
  130. 130
    Bénédicte Neven, Anne-Marie Prieur, Pierre Quartier dit Maire, Cryopyrinopathies: update on pathogenesis and treatment, Nature Clinical Practice Rheumatology, 2008, 4, 9, 481

    CrossRef

  131. 131
    Eva Dahlén, Karin Barchan, Daniel Herrlander, Patrik Höjman, Marie Karlsson, Lill Ljung, Mats Andersson, Eva Bäckman, Ann-Christin Malmborg Hager, Björn Walse, Leo Joosten, Wim van den Berg, Development of Interleukin-1 Receptor Antagonist Mutants with Enhanced Antagonistic ActivityIn Vitroand Improved Therapeutic Efficacy in Collagen-Induced Arthritis, Journal of Immunotoxicology, 2008, 5, 2, 189

    CrossRef

  132. 132
    Marco Gattorno, Silvia Federici, Maria Antonietta Pelagatti, Roberta Caorsi, Giacomo Brisca, Clara Malattia, Alberto Martini, Diagnosis and Management of Autoinflammatory Diseases in Childhood, Journal of Clinical Immunology, 2008, 28, S1, 73

    CrossRef

  133. 133
    Lindsey A. Brodell, Lisa A. Beck, Differential diagnosis of chronic urticaria, Annals of Allergy, Asthma & Immunology, 2008, 100, 3, 181

    CrossRef

  134. 134
    M. Saito, R. Nishikomori, N. Kambe, A. Fujisawa, H. Tanizaki, K. Takeichi, T. Imagawa, T. Iehara, H. Takada, T. Matsubayashi, H. Tanaka, H. Kawashima, K. Kawakami, S. Kagami, I. Okafuji, T. Yoshioka, S. Adachi, T. Heike, Y. Miyachi, T. Nakahata, Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients, Blood, 2008, 111, 4, 2132

    CrossRef

  135. 135
    Hal M. Hoffman, Martin L. Throne, N. J. Amar, Mohamed Sebai, Alan J. Kivitz, Arthur Kavanaugh, Steven P. Weinstein, Pavel Belomestnov, George D. Yancopoulos, Neil Stahl, Scott J. Mellis, Efficacy and safety of rilonacept (interleukin-1 trap) in patients with cryopyrin-associated periodic syndromes: Results from two sequential placebo-controlled studies, Arthritis & Rheumatism, 2008, 58, 8
  136. 136
    Juan I. Aróstegui, Jordi Yagüe, Enfermedades autoinflamatorias sistémicas hereditarias. Parte II: síndromes periódicos asociados a criopirina, granulomatosis sistémicas pediátricas y síndrome PAPA, Medicina Clínica, 2008, 130, 11, 429

    CrossRef

  137. 137
    Yasuyo Kashiwagi, Hisashi Kawashima, Shigeo Nishimata, Ryuhei Nagao, Kiyoko Watanabe, Kouji Takekuma, Akinori Hoshika, Extreme efficiency of anti-interleukin 1 agent (anakinra) in a Japanese case of CINCA syndrome, Clinical Rheumatology, 2008, 27, 2, 277

    CrossRef

  138. 138
    Lars Iversen, Claus Johansen, Inflammasomes and inflammatory caspases in skin inflammation, Expert Review of Molecular Diagnostics, 2008, 8, 6, 697

    CrossRef

  139. 139
    Ki-Hong Kim, Jung-Hyun Shim, Eun-Hee Seo, Min-Chul Cho, Jung-Woo Kang, Soo-Hyun Kim, Dae-Yeul Yu, Eun-Young Song, Hee-Gu Lee, Jung-Hoon Sohn, JinMan Kim, Charles A. Dinarello, Do-Young Yoon, Interleukin-32 monoclonal antibodies for Immunohistochemistry, Western blotting, and ELISA, Journal of Immunological Methods, 2008, 333, 1-2, 38

    CrossRef

  140. 140
    Leigh D Church, Graham P Cook, Michael F McDermott, Primer: inflammasomes and interleukin 1β in inflammatory disorders, Nature Clinical Practice Rheumatology, 2008, 4, 1, 34

    CrossRef

  141. 141
    K. Stankovic, G. Grateau, Quoi de neuf dans les maladies auto-inflammatoires ?, La Revue de Médecine Interne, 2008, 29, 12, 994

    CrossRef

  142. 142
    George D Kalliolias, Stamatis-Nick C Liossis, The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis, Expert Opinion on Investigational Drugs, 2008, 17, 3, 349

    CrossRef

  143. 143
    Marco Gattorno, Alessandra Piccini, Denise Lasigliè, Sara Tassi, Giacomo Brisca, Sonia Carta, Laura Delfino, Francesca Ferlito, Maria Antonietta Pelagatti, Francesco Caroli, Antonella Buoncompagni, Stefania Viola, Anna Loy, Marina Sironi, Annunciata Vecchi, Angelo Ravelli, Alberto Martini, Anna Rubartelli, The pattern of response to anti–interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis, Arthritis & Rheumatism, 2008, 58, 5
  144. 144
    Mihai G Netea, Frank L van de Veerdonk, Bart Jan Kullberg, Jos W M Van der Meer, Leo A B Joosten, The role of NLRs and TLRs in the activation of the inflammasome, Expert Opinion on Biological Therapy, 2008, 8, 12, 1867

    CrossRef

  145. 145
    Rachel L. Glaser, Raphaela Goldbach-Mansky, The spectrum of monogenic autoinflammatory syndromes: Understanding disease mechanisms and use of targeted therapies, Current Allergy and Asthma Reports, 2008, 8, 4, 288

    CrossRef

  146. 146
    T Pettersson, YT Konttinen, CPJ Maury, Treatment strategies for amyloid A amyloidosis, Expert Opinion on Pharmacotherapy, 2008, 9, 12, 2117

    CrossRef

  147. 147
    David Weldon, Your patients are itching for answers, Annals of Allergy, Asthma & Immunology, 2008, 100, 3, 191

    CrossRef

  148. 148
    Ryuji Koike, Tetsuo Kubota, Yukichi Hara, Sayaka Ito, Kyoko Suzuki, Kayoko Yanagisawa, Ken Uchibori, Nobuyuki Miyasaka, A case of Muckle–Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin), Modern Rheumatology, 2007, 17, 6, 496

    CrossRef

  149. 149
    Ryuji Koike, Tetsuo Kubota, Yukichi Hara, Sayaka Ito, Kyoko Suzuki, Kayoko Yanagisawa, Ken Uchibori, Nobuyuki Miyasaka, A case of Muckle–Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin), Modern Rheumatology, 2007, 17, 6, 496

    CrossRef

  150. 150
    Annick Mayor, Fabio Martinon, Thibaut De Smedt, Virginie Pétrilli, Jürg Tschopp, A crucial function of SGT1 and HSP90 in inflammasome activity links mammalian and plant innate immune responses, Nature Immunology, 2007, 8, 5, 497

    CrossRef

  151. 151
    José Luis Callejas, Javier Oliver, Javier Martín, Norberto Ortego, Anakinra in mutation-negative CINCA syndrome, Clinical Rheumatology, 2007, 26, 4, 576

    CrossRef

  152. 152
    Dan C Nordström, Anakinra in the treatment of rheumatoid arthritis and other IL-1-driven conditions, Future Rheumatology, 2007, 2, 4, 353

    CrossRef

  153. 153
    Shai Padeh, Yakov Berkun, Auto-inflammatory Fever Syndromes, Rheumatic Disease Clinics of North America, 2007, 33, 3, 585

    CrossRef

  154. 154
    Nobuo KANAZAWA, Fukumi FURUKAWA, Autoinflammatory syndromes with a dermatological perspective, The Journal of Dermatology, 2007, 34, 9
  155. 155
    Tetsuo KUBOTA, Ryuji KOIKE, Biological and clinical aspects of Muckle-Wells syndrome, Japanese Journal of Clinical Immunology, 2007, 30, 2, 114

    CrossRef

  156. 156
    F. Allantaz, D. Chaussabel, D. Stichweh, L. Bennett, W. Allman, A. Mejias, M. Ardura, W. Chung, E. Smith, C. Wise, K. Palucka, O. Ramilo, M. Punaro, J. Banchereau, V. Pascual, Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade, Journal of Experimental Medicine, 2007, 204, 9, 2131

    CrossRef

  157. 157
    Hiroshi SUGIURA, Tadashi MATSUBAYASHI, Clinical features of CINCA syndrome: effects and problems of IL-1Ra., Japanese Journal of Clinical Immunology, 2007, 30, 2, 108

    CrossRef

  158. 158
    Nathalie Klemmer, Pascal Lenain, Xavier Balguerie, Xavier Le Loët, Effectiveness of anti-IL1 in Schnitzler's syndrome, Joint Bone Spine, 2007, 74, 5, 509

    CrossRef

  159. 159
    Nathalie Klemmer, Pascal Lenain, Xavier Balguerie, Xavier Le Loët, Efficacité de l'anti-IL1 dans le syndrome de Schnitzler, Revue du Rhumatisme, 2007, 74, 9, 914

    CrossRef

  160. 160
    Hal M. Hoffman, Hereditary immunologic disorders caused by pyrin and cryopyrin, Current Allergy and Asthma Reports, 2007, 7, 5, 323

    CrossRef

  161. You have free access to this content161
    Charles A. Dinarello, Historical insights into cytokines, European Journal of Immunology, 2007, 37, S1
  162. 162
    Florence Allantaz, Dorothee Stichweh, Virginia Pascual, Interleukin-1 as a therapeutic target in systemic-onset juvenile idiopathic arthritis, Future Rheumatology, 2007, 2, 3, 305

    CrossRef

  163. 163
    Charles A. Dinarello, Interleukin-18 and the Pathogenesis of Inflammatory Diseases, Seminars in Nephrology, 2007, 27, 1, 98

    CrossRef

  164. 164
    Virginie Pétrilli, Fabio Martinon, L'inflammasome, les maladies auto-inflammatoires et la goutte, Revue du Rhumatisme, 2007, 74, 12, 1240

    CrossRef

  165. 165
    Stéphanie Gerard, Benoît le Goff, Yves Maugars, Jean-Marie Berthelot, Olivier Malard, Lasting remission of a Muckle–Wells syndrome with CIAS-1 mutation using half-dose anakinra, Joint Bone Spine, 2007, 74, 6, 659

    CrossRef

  166. 166
    Stephen B. Willingham, Daniel T. Bergstralh, William O'Connor, Amy C. Morrison, Debra J. Taxman, Joseph A. Duncan, Shoshana Barnoy, Malabi M. Venkatesan, Richard A. Flavell, Mohanish Deshmukh, Hal M. Hoffman, Jenny P.-Y. Ting, Microbial Pathogen-Induced Necrotic Cell Death Mediated by the Inflammasome Components CIAS1/Cryopyrin/NLRP3 and ASC, Cell Host & Microbe, 2007, 2, 3, 147

    CrossRef

  167. 167
    Charles A. Dinarello, Mutations in cryopyrin: Bypassing roadblocks in the caspase 1 inflammasome for interleukin-1β secretion and disease activity, Arthritis & Rheumatism, 2007, 56, 9
  168. 168
    A. So, Neue Erkenntnisse zur Pathophysiologie und Therapie der Gicht, Zeitschrift für Rheumatologie, 2007, 66, 7, 562

    CrossRef

  169. 169
    Maria M Picken, New insights into systemic amyloidosis: the importance of diagnosis of specific type, Current Opinion in Nephrology and Hypertension, 2007, 16, 3, 196

    CrossRef

  170. 170
    Philip Rosenstiel, Andreas Till, Stefan Schreiber, NOD-like receptors and human diseases, Microbes and Infection, 2007, 9, 5, 648

    CrossRef

  171. 171
    Juan I. Aróstegui, Cristina Arnal, Rosa Merino, Consuelo Modesto, María Antonia Carballo, Purificación Moreno, Julia García-Consuegra, Antonio Naranjo, Eduardo Ramos, Pilar de Paz, Josefa Rius, Susana Plaza, Jordi Yagüe, NOD2 gene–associated pediatric granulomatous arthritis: Clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort, Arthritis & Rheumatism, 2007, 56, 11
  172. 172
    Christopher A. Gabel, P2 purinergic receptor modulation of cytokine production, Purinergic Signalling, 2007, 3, 1-2, 27

    CrossRef

  173. 173
    Marco Gattorno, Sara Tassi, Sonia Carta, Laura Delfino, Francesca Ferlito, Maria Antonietta Pelagatti, Andrea D'Osualdo, Antonella Buoncompagni, Maria Giannina Alpigiani, Maria Alessio, Alberto Martini, Anna Rubartelli, Pattern of interleukin-1β secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations, Arthritis & Rheumatism, 2007, 56, 9
  174. 174
    Thierry Lequerré, Olivier Vittecoq, Xavier Le Loët, Quelle est la place actuelle de l'IL-1Ra dans les maladies rhumatismales?, Revue du Rhumatisme, 2007, 74, 5, 435

    CrossRef

  175. 175
    Daniel C. Knockaert, Recurrent Fevers of Unknown Origin, Infectious Disease Clinics of North America, 2007, 21, 4, 1189

    CrossRef

  176. 176
    Stéphanie Gerard, Benoît le Goff, Yves Maugars, Olivier Malard, Jean-Marie Berthelot, Rémission durable d'un syndrome de Muckle-Wells avec mutation du gène CIAS-1, grâce à une demi-dose (100 mg un jour sur deux) d'anakinra, Revue du Rhumatisme, 2007, 74, 12, 1336

    CrossRef

  177. 177
    Susan M. O'Connell, Grainne M. O'Regan, Turlough Bolger, Hal. M. Hoffman, Andrew Cant, Alan D. Irvine, Rosemarie M. Watson, Response to IL-1-Receptor Antagonist in a Child with Familial Cold Autoinflammatory Syndrome, Pediatric Dermatology, 2007, 24, 1
  178. 178
    Heleen D. de Koning, Evelien J. Bodar, Jos W.M. van der Meer, Anna Simon, Schnitzler Syndrome: Beyond the Case Reports: Review and Follow-Up of 94 Patients with an Emphasis on Prognosis and Treatment, Seminars in Arthritis and Rheumatism, 2007, 37, 3, 137

    CrossRef

  179. 179
    Elisabeth Eiling, Maike Möller, Inga Kreiselmaier, Jochen Brasch, Thomas Schwarz, Schnitzler syndrome: Treatment failure to rituximab but response to anakinra, Journal of the American Academy of Dermatology, 2007, 57, 2, 361

    CrossRef

  180. 180
    Rohan Crouch, Victoria Akhras, Robert Sarkany, Schnitzler's syndrome: Successful treatment with anakinra, Australasian Journal of Dermatology, 2007, 48, 3
  181. 181
    James B. Johnston, Masmudur M. Rahman, Grant McFadden, Strategies that modulate inflammasomes—insights from host–pathogen interactions, Seminars in Immunopathology, 2007, 29, 3, 261

    CrossRef

  182. 182
    Brian D. Thornton, Hal M. Hoffman, Adarsh Bhat, Burl R. Don, Successful Treatment of Renal Amyloidosis Due to Familial Cold Autoinflammatory Syndrome Using an Interleukin 1 Receptor Antagonist, American Journal of Kidney Diseases, 2007, 49, 3, 477

    CrossRef

  183. 183
    Puja Chitkara, Silvia Stojanov, Daniel L. Kastner, The Hereditary Autoinflammatory Syndromes, The Pediatric Infectious Disease Journal, 2007, 26, 4, 353

    CrossRef

  184. 184
    Virginie Pétrilli, Fabio Martinon, The inflammasome, autoinflammatory diseases, and gout, Joint Bone Spine, 2007, 74, 6, 571

    CrossRef

  185. 185
    Ronald M. Ferdman, Urticaria and Angioedema, Clinical Pediatric Emergency Medicine, 2007, 8, 2, 72

    CrossRef

  186. 186
    Thierry Lequerré, Olivier Vittecoq, Xavier le Loët, What is the role for interleukin-1 receptor antagonist in rheumatic disease?, Joint Bone Spine, 2007, 74, 3, 223

    CrossRef

  187. 187
    Cem Gabay, William Arend, Contemporary Targeted Therapies in Rheumatology, 2007,

    CrossRef

  188. 188
    Daniel C Knockaert, Fever of Unknown Origin, 2007,

    CrossRef

  189. 189
    Loes M. Kuijk, Hal M. Hoffman, Bénédicte Neven, Joost Frenkel, Pediatrics in Systemic Autoimmune Diseases, 2007,

    CrossRef

  190. 190
    Shinji KAGAMI, Hidehisa SAEKI, Yoshihiro KUWANO, Sumihisa IMAKADO, Kunihiko TAMAKI, A probable case of Muckle–Wells syndrome, The Journal of Dermatology, 2006, 33, 2
  191. 191
    Saskia H. L. Mandey, Loes M. Kuijk, Joost Frenkel, Hans R. Waterham, A role for geranylgeranylation in interleukin-1β secretion, Arthritis & Rheumatism, 2006, 54, 11
  192. 192
    Roy Fleischmann, Anakinra in the treatment of rheumatic disease, Expert Review of Clinical Immunology, 2006, 2, 3, 331

    CrossRef

  193. 193
    Tadashi Matsubayashi, Hiroshi Sugiura, Takashi Arai, Tsutomu Oh-Ishi, Yasuji Inamo, Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene, Acta Paediatrica, 2006, 95, 2
  194. 194
    Tadashi Matsubayashi, Hiroshi Sugiura, Takashi Arai, Tsutomu Oh-Ishi, Yasuji Inamo, Anakinra therapy for CINCA syndrome with a novel mutation in exon 4 of the CIAS1 gene, Acta Paediatrica, 2006, 95, 2, 246

    CrossRef

  195. 195
    Manop Pithukpakorn, Ivona Aksentijevich, Jorge R. Toro, Autoinflammatory Diseases: Clinical and Dermatologic Features, Genetics, Pathogenesis and Therapy, Advances in Dermatology, 2006, 22, 67

    CrossRef

  196. 196
    SUSAN J. LEE, ARTHUR KAVANAUGH, Biologic Agents in Rheumatology: Safety Considerations, Rheumatic Disease Clinics of North America, 2006, 32, 3

    CrossRef

  197. 197
    Nele Festjens, Sigrid Cornelis, Mohamed Lamkanfi, Peter Vandenabeele, Caspase-containing complexes in the regulation of cell death and inflammation, Biological Chemistry, 2006, 387, 8

    CrossRef

  198. 198
    Jonathan Samuels, Seza Ozen, Familial Mediterranean fever and the other autoinflammatory syndromes: evaluation of the patient with recurrent fever, Current Opinion in Rheumatology, 2006, 18, 1, 108

    CrossRef

  199. 199
    C. Huemer, M. Huemer, Genetische Fiebersyndrome, Zeitschrift für Rheumatologie, 2006, 65, 7, 595

    CrossRef

  200. 200
    Leigh D. Church, Sarah M. Churchman, Philip N. Hawkins, Michael F. McDermott, Hereditary auto-inflammatory disorders and biologics, Springer Seminars in Immunopathology, 2006, 27, 4, 494

    CrossRef

  201. 201
    Etienne Meylan, Jürg Tschopp, Michael Karin, Intracellular pattern recognition receptors in the host response, Nature, 2006, 442, 7098, 39

    CrossRef

  202. 202
    Danielle Burger, Jean-Michel Dayer, Gaby Palmer, Cem Gabay, Is IL-1 a good therapeutic target in the treatment of arthritis?, Best Practice & Research Clinical Rheumatology, 2006, 20, 5, 879

    CrossRef

  203. 203
    Raphaela Goldbach-Mansky, Natalie J. Dailey, Scott W. Canna, Ana Gelabert, Janet Jones, Benjamin I. Rubin, H. Jeffrey Kim, Carmen Brewer, Christopher Zalewski, Edythe Wiggs, Suvimol Hill, Maria L. Turner, Barbara I. Karp, Ivona Aksentijevich, Frank Pucino, Scott R. Penzak, Margje H. Haverkamp, Leonard Stein, Barbara S. Adams, Terry L. Moore, Robert C. Fuhlbrigge, Bracha Shaham, James N. Jarvis, Kathleen O'Neil, Richard K. Vehe, Laurie O. Beitz, Gregory Gardner, William P. Hannan, Robert W. Warren, William Horn, Joe L. Cole, Scott M. Paul, Philip N. Hawkins, Tuyet Hang Pham, Christopher Snyder, Robert A. Wesley, Steven C. Hoffmann, Steven M. Holland, John A. Butman, Daniel L. Kastner, Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition, New England Journal of Medicine, 2006, 355, 6, 581

    CrossRef

  204. 204
    C. Boschan, O. Witt, P. Lohse, I. Foeldvari, H. Zappel, L. Schweigerer, Neonatal-onset multisystem inflammatory disease (NOMID) due to a novel S331R mutation of the CIAS1 gene and response to interleukin-1 receptor antagonist treatment, American Journal of Medical Genetics Part A, 2006, 140A, 8
  205. 205
    Christine Savage, E. William St. Clair, New Therapeutics in Rheumatoid Arthritis, Rheumatic Disease Clinics of North America, 2006, 32, 1, 57

    CrossRef

  206. 206
    Tristan Mirault, David Launay, Laurence Cuisset, Eric Hachulla, Marc Lambert, Viviane Queyrel, Thomas Quemeneur, Sandrine Morell-Dubois, Pierre-Yves Hatron, Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra, Arthritis & Rheumatism, 2006, 54, 5
  207. 207
    Francis J Dumont, The interleukin-1 families of cytokines and receptors: therapeutic potential for immunomodulation and the treatment of inflammatory disorders, Expert Opinion on Therapeutic Patents, 2006, 16, 7, 879

    CrossRef

  208. 208
    Donato Rigante, Valentina Ansuini, Barbara Bertoni, Anna Lisa Pugliese, Laura Avallone, Gilda Federico, Achille Stabile, Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome, Rheumatology International, 2006, 27, 1, 97

    CrossRef

  209. 209
    Joseph A Markenson, New advances in interleukin-1 blockade for the treatment of rheumatoid arthritis, Therapy, 2005, 2, 3, 447

    CrossRef

  210. 210
    Charles A. Dinarello, An IL-1 Family Member Requires Caspase-1 Processing and Signals through the ST2 Receptor, Immunity, 2005, 23, 5, 461

    CrossRef

  211. 211
    F. Caux, L. Maksimovic, J. Stirnemann, L. Cuisset, S. Rouaghe, E. Letellier, O. Fain, L. Laroche, C30 - Efficacité de l’anakinra et nouvelle mutation du gène CIAS1 dans le syndrome de Muckle-Wells : 3 cas, Annales de Dermatologie et de Vénéréologie, 2005, 132, 20

    CrossRef

  212. 212
    Jenny P-Y. Ting, Beckley K. Davis, CATERPILLER: A Novel Gene Family Important in Immunity, Cell Death, and Diseases, Annual Review of Immunology, 2005, 23, 1, 387

    CrossRef

  213. 213
    Silvia Stojanov, Daniel L Kastner, Familial autoinflammatory diseases: genetics, pathogenesis and treatment, Current Opinion in Rheumatology, 2005, 17, 5, 586

    CrossRef

  214. 214
    Gregory C. Gardner, Inflammatory arthritis in the era of the biologics, Clinical and Applied Immunology Reviews, 2005, 5, 1, 19

    CrossRef

  215. 215
    Charles A Dinarello, Gilles Kaplanski, Interleukin-18 treatment options for inflammatory diseases, Expert Review of Clinical Immunology, 2005, 1, 4, 619

    CrossRef

  216. 216
    Soo-Hyun Kim, Sun-Young Han, Tania Azam, Do-Young Yoon, Charles A. Dinarello, Interleukin-32, Immunity, 2005, 22, 1, 131

    CrossRef

  217. 217
    Daniel J. Lovell, Suzanne L. Bowyer, Alan M. Solinger, Interleukin-1 blockade by anakinra improves clinical symptoms in patients with neonatal-onset multisystem inflammatory disease, Arthritis & Rheumatism, 2005, 52, 4
  218. 218
    P. Vinceneux, J. Pouchot, La maladie périodique au sein des maladies auto-inflammatoires, La Presse Médicale, 2005, 34, 13, 947

    CrossRef

  219. 219
    Joseph A Markenson, New advances in interleukin-1 blockade for the treatment of rheumatoid arthritis, Therapy, 2005, 2, 3, 447

    CrossRef

  220. 220
    Naohiro Inohara, Mathias Chamaillard, Christine McDonald, Gabriel Nuñez, NOD-LRR PROTEINS: Role in Host-Microbial Interactions and Inflammatory Disease, Annual Review of Biochemistry, 2005, 74, 1, 355

    CrossRef

  221. 221
    Shai Padeh, Periodic Fever Syndromes, Pediatric Clinics of North America, 2005, 52, 2, 577

    CrossRef

  222. 222
    Avril A. Fitzgerald, Sharon A. LeClercq, Alexander Yan, Joanne E. Homik, Charles A. Dinarello, Rapid responses to anakinra in patients with refractory adult-onset Still's disease, Arthritis & Rheumatism, 2005, 52, 6
  223. 223
    Victor Manuel Martinez-Taboada, Ana Fontalba, Ricardo Blanco, Jose Luis Fernández-Luna, Successful treatment of refractory Schnitzler syndrome with anakinra: Comment on the article by Hawkins et al, Arthritis & Rheumatism, 2005, 52, 7
  224. 224
    Charles A. Dinarello, The many worlds of reducing interleukin-1, Arthritis & Rheumatism, 2005, 52, 7
  225. 225
    Manfred Zierhut, Hartmut Michels, Nicole St??biger, Dorothea Besch, Christoph Deuter, Arnd Heiligenhaus, Uveitis in Children, International Ophthalmology Clinics, 2005, 45, 2, 135

    CrossRef

  226. 226
    Sophie Launay, Olivier Hermine, Michaëla Fontenay, Guido Kroemer, Eric Solary, Carmen Garrido, Vital functions for lethal caspases, Oncogene, 2005, 24, 33, 5137

    CrossRef

  227. 227
    Joost Frenkel, Nico M. Wulffraat, Wietse Kuis, Anakinra in mutation-negative NOMID/CINCA syndrome: Comment on the articles by Hawkins et al and Hoffman and Patel, Arthritis & Rheumatism, 2004, 50, 11
  228. 228
    Juan I. Aróstegui, Anna Aldea, Consuelo Modesto, Maria Jesús Rua, Federico Argüelles, Maria Antonia González-Enseñat, Eduardo Ramos, Josefa Rius, Susana Plaza, Jordi Vives, Jordi Yagüe, Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene, Arthritis & Rheumatism, 2004, 50, 12
  229. 229
    J.-K. Lee, S.-H. Kim, E. C. Lewis, T. Azam, L. L. Reznikov, C. A. Dinarello, Differences in signaling pathways by IL-1  and IL-18, Proceedings of the National Academy of Sciences, 2004, 101, 23, 8815

    CrossRef

  230. 230
    Riny Janssen, Els Verhard, Arjan Lankester, Rebecca ten Cate, Jaap T. van Dissel, Enhanced interleukin-1β and interleukin-18 release in a patient with chronic infantile neurologic, cutaneous, articular syndrome, Arthritis & Rheumatism, 2004, 50, 10
  231. 231
    Fabio Martinon, Jürg Tschopp, Inflammatory Caspases, Cell, 2004, 117, 5, 561

    CrossRef

  232. 232
    Laetitia Agostini, Fabio Martinon, Kimberly Burns, Michael F. McDermott, Philip N. Hawkins, Jürg Tschopp, NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder, Immunity, 2004, 20, 3, 319

    CrossRef

  233. 233
    Hal M Hoffman, Sanna Rosengren, David L Boyle, Jae Y Cho, Jyothi Nayar, James L Mueller, Justin P Anderson, Alan A Wanderer, Gary S Firestein, Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist, The Lancet, 2004, 364, 9447, 1779

    CrossRef

  234. 234
    Nora G Singer, Lisabeth V Scalzi, Remittive agents in pediatric rheumatology, Current Opinion in Rheumatology, 2004, 16, 5, 571

    CrossRef

  235. 235
    Philip N. Hawkins, Alison Bybee, Ebun Aganna, Michael F. McDermott, Response to anakinra in a de novo case of neonatal-onset multisystem inflammatory disease, Arthritis & Rheumatism, 2004, 50, 8
  236. 236
    Joel D Abbott, Larry W Moreland, Rheumatoid arthritis: developing pharmacological therapies, Expert Opinion on Investigational Drugs, 2004, 13, 8, 1007

    CrossRef

  237. 237
    Martin Braddock, Anthony Quinn, Jan Canvin, Therapeutic potential of targeting IL-1 and IL-18 in inflammation, Expert Opinion on Biological Therapy, 2004, 4, 6, 847

    CrossRef

  238. 238
    Charles A. Dinarello, Unraveling the NALP-3/IL-1β Inflammasome, Immunity, 2004, 20, 3, 243

    CrossRef

  239. 239
    Penelope Ward, Mark Bodmer, Antibodies in Phase III Studies for Immunological Disorders,
  240. 240
    R. P. E. Sarkany, S. M. Breathnach, A. A. M. Morris, K. Weismann, P. D. Flynn, Metabolic and Nutritional Disorders,
  241. 241
    S. M. Breathnach, C. H. Smith, R. J. G. Chalmers, R. J. Hay, Systemic Therapy,